143 related articles for article (PubMed ID: 6346856)
1. A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Smith BJ; Ashford RF; Bakowski M; Hellman K; Newton K; Phillips R; Lambert J; Jones R; Peters N; Evans M
Am J Clin Oncol; 1983 Aug; 6(4):481-4. PubMed ID: 6346856
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
3. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
Krauss S; Sonoda T; Solomon A
Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
[No Abstract] [Full Text] [Related]
5. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
[TBL] [Abstract][Full Text] [Related]
6. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
7. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal tumors: chemotherapeutic preparations].
Queisser W; Heim ME
Fortschr Med; 1983 Apr; 101(13):583-6. PubMed ID: 6852723
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
[No Abstract] [Full Text] [Related]
10. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
DeSimone PA; Greco FA; Omura GA; Bartolucci A
Am J Clin Oncol; 1986 Jun; 9(3):185-6. PubMed ID: 3728369
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
Cedermark BJ; Gunven P; Hammarberg C
J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Vogl SE; Lanham R; Kaplan BH
Oncology; 1980; 37(5):314-5. PubMed ID: 7003455
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of gastrointestinal cancer.
Moertel CG
N Engl J Med; 1978 Nov; 299(19):1049-52. PubMed ID: 360064
[No Abstract] [Full Text] [Related]
17. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
Moertel CG
JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
[No Abstract] [Full Text] [Related]
18. Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
Slevin ML; Harvey VJ; Wrigley PF
Cancer Chemother Pharmacol; 1983; 10(3):228-9. PubMed ID: 6345019
[No Abstract] [Full Text] [Related]
19. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
20. Clinical strategies in the chemotherapy of gastrointestinal cancer.
Macdonald JS; Woolley PV; Schein PS
Recent Results Cancer Res; 1980; 70():179-85. PubMed ID: 6986641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
